The first nationwide implementation of pharmaceutical care practices through a continuing professional development approach for community pharmacists Sule ApikogluAysu SelcukArman Uney ESCP Best Practice 14 June 2022 Pages: 1223 - 1231
Efficacy and treatment-related adverse events of multi-targeted tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials Keqian ZhangWenwei WangLan Liang Review Article 11 August 2022 Pages: 1232 - 1246
Exploring the impact of suicide care experiences and post-intervention supports sought among community pharmacists: a cross-sectional survey Sarira El-DenHuai-Jin ChoongClaire L. O’Reilly Research Article Open access 20 April 2022 Pages: 1247 - 1258
Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study Oumaima AalouchMarjolijn Duisenberg-van EssenbergPatricia M. L. A. van den Bemt Research Article 11 July 2022 Pages: 1259 - 1268
Evaluation of a post-discharge pharmacist opioid review following total knee arthroplasty: a pre- and post-intervention cohort study Tim TranJames FordRohan A. Elliott Research Article 12 July 2022 Pages: 1269 - 1276
Risk factors associated with augmented renal clearance in a mixed intensive care unit population: a retrospective study Emily BingKym ArchambaultMarc M. Perreault Research Article 14 July 2022 Pages: 1277 - 1286
Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial Zhihong LiZhaobo GuanWeihong Chen Research Article 27 July 2022 Pages: 1287 - 1295
Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study Kebede BeyeneWilson ShenAmy Hai Yan Chan Research Article 27 July 2022 Pages: 1296 - 1303
Predicting adverse drug events in older inpatients: a machine learning study Qiaozhi HuBin WuTing Xu Research Article 17 September 2022 Pages: 1304 - 1311
Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums Abdulaziz Saud AlzahraniSheila M. GreenfieldVibhu Paudyal Research Article Open access 22 September 2022 Pages: 1312 - 1324
Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations Liming WangXiaolan LinSongqing Shi Research Article 22 September 2022 Pages: 1325 - 1331
Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance Takuro OkadaMasayuki HashiguchiSatoko Hori Research Article 26 September 2022 Pages: 1332 - 1341
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country Nancy ZaghloulAhmed AwaisuHazem Elewa Research Article Open access 28 September 2022 Pages: 1342 - 1350
Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system Jiao-Jiao ChenXue-Chen HuoQuan Zhao Research Article 30 September 2022 Pages: 1351 - 1360
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study Ran NissanIrridea GezinAvital Hershkovitz Research Article 05 October 2022 Pages: 1361 - 1369
Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study Steven RoweNicole PittmanDeborah V Kelly Research Article 06 October 2022 Pages: 1370 - 1379
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study Robert MoeckerAndreas FuchsHanna M. Seidling Research Article Open access 08 October 2022 Pages: 1380 - 1393
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children Jennifer C. DuncanLouise E. BrackenMark A. Turner Research Article Open access 08 October 2022 Pages: 1394 - 1405
Designing an evidence based community pharmacy service specification for a pharmacogenomic testing service Tim RendellJulie BarnettDavid Wright Research Article Open access 10 October 2022 Pages: 1406 - 1416
General practice pharmacists’ implementation of advanced clinical assessment skills: a qualitative study of behavioural determinants Gordon F. RushworthTesnime JebaraScott Cunningham Research Article Open access 10 October 2022 Pages: 1417 - 1424
SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports Hibathulla PalapraSubeesh K. ViswamKrishna Undela Research Article 12 October 2022 Pages: 1425 - 1433
Correlation between the number of patient-reported adverse events, adverse drug events, and quality of life in older patients: an observational study Cathelijn J. Beerlage-DavidsGodelieve H. M. PonjeeFatma Karapinar-Çarkit Research Article 15 October 2022 Pages: 1434 - 1441
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C Medo GutićMiloš N. MilosavljevićSlobodan M. Janković Research Article 15 October 2022 Pages: 1442 - 1453
Identifying mental health training needs of general practice pharmacy workforce to advance practice: a training needs analysis survey Chris F. JohnsonKatie Earle-Payne Research Article 25 October 2022 Pages: 1454 - 1463
50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care Conference abstracts 03 December 2022 Pages: 1464 - 1566
Publisher Correction to: Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial Zhihong LiZhaobo GuanWeihong Chen Publisher Correction 02 November 2022 Pages: 1567 - 1567
Author Correction to: Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study Oumaima AalouchMarjolijn Duisenberg-van EssenbergPatricia M. L. A. van den Bemt Author Correction 25 October 2022 Pages: 1568 - 1571
Publisher Correction to: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis Yuying CuiYingxue Guo Publisher Correction 17 October 2022 Pages: 1572 - 1572
Publisher Correction to: Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study Laurie E. DaviesAndrew KingstonBarbara Hanratty Publisher Correction Open access 31 October 2022 Pages: 1573 - 1573
